Register Now
The Conference
Program
Speakers
Advisory Board
Sponsors
Testimonials
Partners
Shape Your Event
Enquiries
Venue & Accommodation
Washington
Networking
Sponsorship & Exhibition
Your opportunities
Who attends
Who exhibits
Testimonials
Enquiries
Event home pages
Phacilitate home page




DynPort Vaccine Company LLC (DVC) manages product development programs for U.S. government agencies, and provides consulting, technical and program management services to companies in the biotechnology and pharmaceutical industries. The company’s portfolio includes vaccines and therapeutics to protect against emerging infectious diseases including biological and chemical warfare threat agents and seasonal and pandemic influenza. DVC is a wholly owned subsidiary of CSC (NYSE: CSC). For more information, visit www.csc.com/dvc.

©Copyright Phacilitate Limited 2010



Click here to download the last three North American Vaccine Forum Main Announcements



Click here to find out how your company can participate.